RayKnowChina Research Map
Shortlist0

Hefei

First Affiliated Hospital of Anhui University of Chinese Medicine

安徽中医药大学第一附属医院

Listed for 3 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at First Affiliated Hospital of Anhui University of Chinese Medicine

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Wilson disease肝豆状核变性(Wilson 病)52 papers led
  2. Amyotrophic lateral sclerosis肌萎缩侧索硬化症2 papers led
  3. IgA nephropathyIgA 肾病5 papers led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Stomach cancer, Hepatoblastoma, Retinoblastoma, Chordoma, Osteosarcoma, Gastrointestinal stromal tumour, Neuroblastoma, Ewing sarcoma, Multiple myeloma, B-cell acute lymphoblastic leukaemia, Aplastic anaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Biliary atresia, Anti-NMDA receptor encephalitis, Takayasu arteritis, Hepatic echinococcosis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Primary sclerosing cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Other diseases

Wilson disease

肝豆状核变性(Wilson 病)

Led 52 of the 201 English-language PubMed papers on Wilson disease with an author in mainland China, 2021–2025: 25.9%.

Papers led
52
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 4420212022: 4420222023: 111120232024: 181820242025: 14142025

4 hospitals in Hefei for Wilson disease28 hospitals in China for Wilson disease

No open trial on Wilson disease lists this hospital on ClinicalTrials.gov on 8 Nov 2026.

The records behind these numbers
ThemesGenetics (ATP7B)Diagnosis & copper testsLiver disease & transplant
Departments in papersNeurologyRadiology / nuclear medicineClinical trials / research unitSurgery (general/hepatobiliary/pancreatic)
Papers it led52
  1. Melatonin ameliorates copper accumulation-induced cognitive impairment in Wilson disease via activation of the SIRT3/FOXO3α signaling pathway.2026Neuropharmacology
  2. Oral Engineered Extracellular Vesicles Based on Ion Exchange Strategy for Multipronged Management of Wilson's Disease Complicated with Reproductive Dysfunction Therapy.2025Advanced science (Weinheim, Baden-Wurttemberg, Germany)Free full text
  3. Risk factors and prediction model development for pancreatic fistula following splenectomy in Wilson's disease patients with portal hypertension.2025BMC gastroenterologyFree full text
  4. Ultrasound-derived fat fraction: a novel approach for assessing Wilson's disease-related hepatic steatosis.2025BMC gastroenterologyFree full text
  5. Social Support, Self-Management Behaviors, and Coping Styles of Patients With Wilson's Disease: A Quantitative Empirical Research.2025Brain and behaviorFree full text
  6. Transcriptional specialization shapes abnormal cortical morphological similarity gradients in Wilson's disease.2025Brain research
  7. Application of Anterior Segment Optical Coherence Tomography in Detecting Kayser-Fleischer Rings in Wilson Disease.2025CorneaFree full text
  8. Review of the Efficacy and Mechanisms of Traditional Chinese Medicine for Treating Multi-Organ Damage in Wilson's Disease.2025Drug design, development and therapyFree full text
  9. Development and validation of a nomogram model for prediction of dyslipidemia in children with Wilson disease: a retrospective analysis.2025Frontiers in endocrinologyFree full text
  10. Role and mechanisms of cuproptosis in the pathogenesis of Wilson's disease (Review).2025International journal of molecular medicineFree full text
  11. Revolutionizing Wilson disease prognosis: a machine learning approach to predict acute-on-chronic liver failure.2025Journal of translational medicineFree full text
  12. Mechanistic Insights Into GDFMD-Mediated Inhibition of Liver Fibrosis via miRNA-29b-3p Upregulation in Wilson's Disease.2025Mediators of inflammationFree full text
  13. Analysis of factors affecting early hepatic steatosis in pediatric patients with Wilson's disease in China: A retrospective study.2025MedicineFree full text
  14. Safety of penicillamine and trientine in the treatment of Wilson's disease: An analysis of the FDA Adverse Event Reporting System (FAERS) database.2025PloS oneFree full text
  15. Evaluation of salivary ceruloplasmin for the diagnosis of Wilson's disease.2025Scientific reportsFree full text
  16. Construction of a nomogram for predicting compensated cirrhosis with Wilson's disease based on non-invasive indicators.2024BMC medical imagingFree full text
  17. Copper exposure induces inflammation and PANoptosis through the TLR4/NF-κB signaling pathway, leading to testicular damage and impaired spermatogenesis in Wilson disease.2024Chemico-biological interactions
  18. Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway.2024Journal of cellular and molecular medicineFree full text
  19. Gandouling induces GSK3β promoter methylation to improve cognitive impairment in Wilson's disease.2024Journal of ethnopharmacology
  20. Berberine alleviates ovarian tissue damage in mice with hepatolenticular degeneration by suppressing ferroptosis and endoplasmic reticulum stress.2024Journal of integrative medicine
  21. Relative exchangeable copper, a high-quality biomarker for differentiation of Traditional Chinese Medicine syndrome in Wilson's disease.2024Journal of traditional Chinese medicine = Chung i tsa chih ying wen panFree full text
  22. Characterization of renal damage in Wilson's disease-Detailed analysis of 20 Chinese cases.2024Medicina clinica
  23. A clinical study showing the expression characteristics of cuproptosis markers in cases with Wilson disease.2024MedicineFree full text
  24. Discussion on the relationship between the distribution characteristics of TCM syndrome types and related objective indicators in hepatolenticular degeneration.2024MedicineFree full text
  25. Network pharmacology-based approach to understand the effect and mechanism of chrysophanol against cognitive impairment in Wilson disease.2024Metabolic brain disease
  26. Transcriptomic evaluation of N6-methyladenosine modification can be used to identify differentially gene and immune-related biological processes in TX mice with liver fibrosis.2024Molecular biology reports
  27. Identification of lncRNA-miRNA-mRNA Networks in the Lenticular Nucleus Region of the Brain Contributes to Hepatolenticular Degeneration Pathogenesis and Therapy.2024Molecular neurobiologyFree full text
  28. From Wilson's Disease to Neurodevelopmental Disorder with Involuntary Movements, Different Genetic Interpretations in a Female Patient.2024Movement disorders : official journal of the Movement Disorder Society
  29. Abnormalities in subcortical function and their treatment response in Wilson's disease.2024NeuroImage. ClinicalFree full text
  30. Serum ceruloplasmin oxidase activity: A neglected diagnostic biomarker for Wilson disease.2024Parkinsonism & related disorders
  31. Assessment and factors affecting quality of life among patients with Wilson's disease.2024Scientific reportsFree full text
  32. 1H-NMR-based metabolomics to dissect the traditional Chinese medicine promotes mesenchymal stem cell homing as intervention in liver fibrosis in mouse model of Wilson's disease.2024The Journal of pharmacy and pharmacology
  33. NK cell exhaustion in Wilson's disease revealed by single-cell RNA sequencing predicts the prognosis of cholecystitis.2024eLifeFree full text
  34. Application of attenuation coefficient in the assessment of hepatic involvement in children and adolescents with Wilson's disease.2023BMC medical imagingFree full text
  35. Large-scale networks changes in Wilson's disease associated with neuropsychiatric impairments: a resting-state functional magnetic resonance imaging study.2023BMC psychiatryFree full text
  36. Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease.2023Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  37. Gandouling alleviates nerve injury through PI3K/Akt/FoxO1 and Sirt1/FoxO1 signaling pathway to inhibit autophagy in the rats model of Wilson's disease.2023Brain and behaviorFree full text
  38. Integrated Metabolomics and Network Pharmacology to Reveal the Mechanisms of Gandouling Tablets Against Copper-Overload-Induced Neuronal Injury in Rats with Wilson's Disease.2023Drug design, development and therapyFree full text
  39. A retrospective cohort study: vaccination status and safety analysis of SARS-CoV-2 vaccine in patients with Wilson's disease.2023Expert review of vaccines
  40. 1H NMR-based metabolomic study of striatal injury in rats with copper-loaded Wilson's disease by Chinese and Western medicine intervention.2023Journal of pharmaceutical and biomedical analysis
  41. Discussion on the Mechanism of Gandoufumu Decoction Attenuates Liver Damage of Wilson's Disease by Inhibiting Autophagy through the PI3K/Akt/mTOR Pathway Based on Network Pharmacology and Experimental Verification.2023Mediators of inflammationFree full text
  42. Comprehensive analysis of the coding and non-coding RNA transcriptome expression profiles of hippocampus tissue in tx-J animal model of Wilson's disease.2023Scientific reportsFree full text
  43. Changes in Hepatic Function After Splenectomy for Hepatolenticular Degeneration, Cirrhosis, and Hypersplenism.2023The American surgeon
  44. Lesions in White Matter in Wilson's Disease and Correlation with Clinical Characteristics.2023The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  45. Nomogram for prediction of portal vein system thrombosis after splenectomy for hypersplenism in patients with Wilson disease.2022Annals of palliative medicine
  46. Liver stiffness assessed by real-time two-dimensional shear wave elastography predicts hypersplenism in patients with Wilson's disease: a prospective study.2022BMC medical imagingFree full text
  47. Copper deposition in Wilson's disease causes male fertility decline by impairing reproductive hormone release through inducing apoptosis and inhibiting ERK signal in hypothalamic-pituitary of mice.2022Frontiers in endocrinologyFree full text
  48. Clinical and genetic characterization of a large cohort of patients with Wilson's disease in China.2022Translational neurodegenerationFree full text
  49. Platelet safety range before splenectomy for hypersplenism: based on 244 cases of splenectomy in hepatolenticular degeneration patients.2021Acta gastro-enterologica Belgica
  50. GanDouLing promotes proliferation and differentiation of neural stem cells in the mouse model of Wilson's disease.2021Bioscience reportsFree full text
  51. Cirrhosis of Wilson's disease: High and low cutoff using acoustic radiation force impulse (ARFI) -Comparison and combination with serum fibrosis index.2021Clinical hemorheology and microcirculation
  52. Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration.2021Scientific reportsFree full text
Chinese-language papers (not in the count)6
  1. [LncRNA Meg3 expression level is negatively correlated with liver fibrosis severity in patients with Wilson disease].2025Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityFree full text
  2. [Gandou Fumu Decoction improves liver steatosis by inhibiting hepatocyte ferroptosis in mice with Wilson's disease through the GPX4/ACSL4/ALOX15 signaling pathway].2025Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityFree full text
  3. [Gandou Bushen Decoction Ameliorates Cognitive Impairment in Wilson Disease Model TX Mice by Regulating Melatonin Synthesis via the SIRT3/FOXO3α Pathway].2025Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science editionFree full text
  4. [Analysis of clinical phenotype and ATP7B variants characteristics of 337 patients with hepatolenticular degeneration in Anhui province].2025Zhonghua yi xue za zhi
  5. [Gandou Bushen Decoction improves spermatogenesis and promotes spermatogenic cell proliferation in Wilson disease TX mice by activating testicular ERK signaling pathway].2024Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityFree full text
  6. [Huangpu Tongqiao Capsule improves cognitive impairment in rats with Wilson disease by inhibiting endoplasmic reticulum stress-mediated apoptosis pathway].2024Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityFree full text
All its trials on ClinicalTrials.gov, any status1
  1. The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson DiseaseCompletedNCT06762509Lead sponsorStart 2016-12

Run the PubMed searchClinicalTrials.gov

Other diseases

Amyotrophic lateral sclerosis

肌萎缩侧索硬化症

Led 2 of the 779 English-language PubMed papers on amyotrophic lateral sclerosis with an author in mainland China, 2021–2025: 0.3%.

Papers led
2
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 1120242025: 002025

2 hospitals in Hefei for amyotrophic lateral sclerosis194 hospitals in China for amyotrophic lateral sclerosis

No open trial on amyotrophic lateral sclerosis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersNeurology
Papers it led2
  1. Genetic causal role of body mass index in multiple neurological diseases.2024Scientific reports
  2. A patient carrying a heterozygous p.Asn267Ser TARDBP missense mutation diagnosed as ALS and only involving lower motor neurons.2023Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Chinese-language papers (not in the count)1
  1. [Clinical analysis of a motor neuron disease-like phenotype associated with anti-IgLON5 disease].2025Zhonghua nei ke za zhi

Run the PubMed searchClinicalTrials.gov

Other diseases

IgA nephropathy

IgA 肾病

Led 5 of the 736 English-language PubMed papers on IgA nephropathy with an author in mainland China, 2021–2025: 0.7%.

Papers led
5
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 442025

4 hospitals in Hefei for IgA nephropathy346 hospitals in China for IgA nephropathy

No open trial on IgA nephropathy lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersNephrology

Over half of these papers are lab or animal studies.

Run the PubMed searchClinicalTrials.gov

Getting in touch

Name card to show staff or a driver

安徽中医药大学第一附属医院

First Affiliated Hospital of Anhui University of Chinese Medicine

合肥

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

No hospital-level ROR record matched.

Suggest a correctionDownload the data